Adnan Khosravi
-
- Lung Cancer Research Studies 9
- HER2/EGFR in Cancer Research 3
-
- Cancer Genomics and Diagnostics 6
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Cancer, Lipids, and Metabolism 3
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 7
- Co-authors
- Esmaeil MortazJohan GarssenPayam TabarsiIan M. AdcockAli Akbar VelayatiDavood MansouriShirin KarimiHamidreza Jamaati
- Cited by
- OncologyImmunologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (6 papers)Frontiers in Immunology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- IranNetherlandsUnited Kingdom
In The Last Decade
Adnan Khosravi
47 papers receiving 442 citations
Peers
Comparison fields: 5 of 94
- Oncology 135
- Immunology 98
- Cancer Research 67
- Pulmonary and Respiratory Medicine 99
- Hematology 29
Countries citing papers authored by Adnan Khosravi
This map shows the geographic impact of Adnan Khosravi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Khosravi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Khosravi more than expected).
Fields of papers citing papers by Adnan Khosravi
This network shows the impact of papers produced by Adnan Khosravi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Khosravi. The network helps show where Adnan Khosravi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adnan Khosravi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 14 | |
| 6 | 2019 | 2 | |
| 7 | 2019 | 4 | |
| 8 | 2018 | 4 | |
| 9 | 2017 | 2 | |
| 10 | Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders. | 2017 | 10 |
| 11 | Expression Of CK19 Gene In Patients With Lung Cancer And Its Comparison With Carcinoembryonic Antigen In Peripheral Blood | 2016 | 2 |
| 12 | 2016 | 10 | |
| 13 | 2015 | 9 | |
| 14 | 2014 | 6 | |
| 15 | 2014 | 3 | |
| 16 | 2012 | 59 | |
| 17 | IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma | 2011 | 1 |
| 18 | Carboplatin plus Paclitaxel in the First Line Therapy of Recurrent and Advances Endometrial Cancer | 2009 | 3 |
| 19 | 2009 | 6 | |
| 20 | 2009 | 19 |
About Adnan Khosravi
Adnan Khosravi is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 454 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Oncology (135 citations), Immunology (98 citations) and Cancer Research (67 citations). Adnan Khosravi has collaborated with scholars based in Iran, Netherlands and United Kingdom. Frequent co-authors include Esmaeil Mortaz, Johan Garssen, Payam Tabarsi, Ian M. Adcock, Ali Akbar Velayati, Davood Mansouri, Shirin Karimi, Hamidreza Jamaati, Mohammad Reza Masjedi and Mostafa Hosseini. Their work appears in journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.